ReviewInternational journal of clinical oncology2022
High-intermediate risk endometrial cancer: moving toward a molecularly based risk assessment profile.
Tavonna D Kako et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it